Core Scientific Common Stock Analysis
| CORZ Stock | USD 15.99 1.43 9.82% |
At this time, Core Scientific's Short and Long Term Debt Total is fairly stable compared to the past year. Long Term Debt is likely to rise to about 1.3 B in 2026, whereas Net Debt is likely to drop slightly above 354.3 M in 2026. With a high degree of financial leverage come high-interest payments, which usually reduce Core Scientific's Earnings Per Share (EPS).
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.68 | Current Value 0.34 | Quarterly Volatility 0.33919662 |
Core Scientific Common is undervalued with Real Value of 17.93 and Target Price of 26.77. The main objective of Core Scientific stock analysis is to determine its intrinsic value, which is an estimate of what Core Scientific Common is worth, separate from its market price. There are two main types of Core Scientific's stock analysis: fundamental analysis and technical analysis.
The Core Scientific stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Core Scientific is usually not traded on Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday. Core Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. Core Stock Analysis Notes
About 93.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.16. Core Scientific Common had not issued any dividends in recent years. Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. Core Scientific operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 205 people. For more info on Core Scientific Common please contact Adam Sullivan at 512 402 5233 or go to https://corescientific.com.Core Scientific Quarterly Total Revenue |
|
Core Scientific Common Investment Alerts
| Core Scientific generated a negative expected return over the last 90 days | |
| Core Scientific has high historical volatility and very poor performance | |
| Core Scientific has a very high chance of going through financial distress in the upcoming years | |
| Core Scientific Common currently holds 1.2 B in liabilities. Core Scientific Common has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Core Scientific's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 510.67 M. Net Loss for the year was (1.32 B) with profit before overhead, payroll, taxes, and interest of 34.13 M. | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from fool.com: A 116 Million Bet on Core Scientific Signals Conviction Beyond Bitcoin Cycles and Headline Volatility |
Core Largest EPS Surprises
Earnings surprises can significantly impact Core Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-08 | 2024-03-31 | 0.13 | 0.16 | 0.03 | 23 | ||
2025-08-08 | 2025-06-30 | 0.01 | -0.04 | -0.05 | 500 | ||
2022-03-29 | 2021-12-31 | 0.33 | 0.41 | 0.08 | 24 |
Core Scientific Environmental, Social, and Governance (ESG) Scores
Core Scientific's ESG score is a quantitative measure that evaluates Core Scientific's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Core Scientific's operations that may have significant financial implications and affect Core Scientific's stock price as well as guide investors towards more socially responsible investments.
Core Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.51 B.Core Profitablity
The company has Profit Margin (PM) of (2.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.95) | (0.99) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.95) | (0.99) | |
| Return On Equity | 1.44 | 0.95 |
Management Efficiency
Core Scientific Common has return on total asset (ROA) of (0.0606) % which means that it has lost $0.0606 on every $100 spent on assets. This is way below average. Core Scientific's management efficiency ratios could be used to measure how well Core Scientific manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.99 in 2026. Return On Capital Employed is likely to drop to -0.02 in 2026. At this time, Core Scientific's Other Current Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 1.1 B in 2026, whereas Total Assets are likely to drop slightly above 1.1 B in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (3.69) | (3.50) | |
| Tangible Book Value Per Share | (3.69) | (3.50) | |
| Enterprise Value Over EBITDA | (3.93) | (3.74) | |
| Price Book Value Ratio | (5.04) | (4.79) | |
| Enterprise Value Multiple | (3.93) | (3.74) | |
| Price Fair Value | (5.04) | (4.79) |
The strategic initiatives led by Core Scientific's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 2nd of January, Core Scientific shows the Mean Deviation of 3.15, standard deviation of 4.0, and Risk Adjusted Performance of (0.02). Core Scientific Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Core Scientific Common Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Core Scientific Common price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Core Scientific Common Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Scientific Outstanding Bonds
Core Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Core Scientific Common uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Core bonds can be classified according to their maturity, which is the date when Core Scientific Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| CoreCivic 475 percent Corp BondUS21871NAA90 | View | |
| US21871DAD57 Corp BondUS21871DAD57 | View |
Core Scientific Predictive Daily Indicators
Core Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1.1 M | |||
| Daily Balance Of Power | 0.9051 | |||
| Rate Of Daily Change | 1.1 | |||
| Day Median Price | 15.35 | |||
| Day Typical Price | 15.56 | |||
| Price Action Indicator | 1.35 | |||
| Period Momentum Indicator | 1.43 |
Core Scientific Corporate Filings
F3 | 18th of December 2025 An amendment to the original Schedule 13D filing | ViewVerify |
F4 | 10th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 1st of December 2025 An amendment to the original Schedule 13D filing | ViewVerify |
F3 | 17th of November 2025 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 14th of November 2025 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 13th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2025 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 6th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Core Scientific Forecast Models
Core Scientific's time-series forecasting models are one of many Core Scientific's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Core Scientific Bond Ratings
Core Scientific Common financial ratings play a critical role in determining how much Core Scientific have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Core Scientific's borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (2.48) | Unlikely Manipulator | View |
Core Scientific Common Debt to Cash Allocation
As Core Scientific Common follows its natural business cycle, the capital allocation decisions will not magically go away. Core Scientific's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Core Scientific Common currently holds 1.2 B in liabilities. Core Scientific Common has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Core Scientific's use of debt, we should always consider it together with its cash and equity.Core Scientific Total Assets Over Time
Core Scientific Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Core Scientific uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Core Scientific Debt Ratio | 34.0 |
Core Scientific Corporate Bonds Issued
Core Short Long Term Debt Total
Short Long Term Debt Total |
|
About Core Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Core Scientific. By using and applying Core Stock analysis, traders can create a robust methodology for identifying Core entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (2.96) | (2.81) | |
| Operating Profit Margin | (0.04) | (0.05) | |
| Net Loss | (2.96) | (2.81) | |
| Gross Profit Margin | 0.21 | 0.17 |
Current Core Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 26.77 | Strong Buy | 16 | Odds |
Most Core analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Scientific Common, talking to its executives and customers, or listening to Core conference calls.
Core Stock Analysis Indicators
Core Scientific Common stock analysis indicators help investors evaluate how Core Scientific stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Scientific shares will generate the highest return on investment. By understating and applying Core Scientific stock analysis, traders can identify Core Scientific position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 69.7 M | |
| Long Term Debt | 1.1 B | |
| Common Stock Shares Outstanding | 255.8 M | |
| Total Stockholder Equity | -820.2 M | |
| Total Cashflows From Investing Activities | -95.2 M | |
| Tax Provision | 859 K | |
| Quarterly Earnings Growth Y O Y | 0.612 | |
| Property Plant And Equipment Net | 670.8 M | |
| Cash And Short Term Investments | 836.2 M | |
| Cash | 836.2 M | |
| Accounts Payable | 19.3 M | |
| Net Debt | 363.6 M | |
| 50 Day M A | 17.2326 | |
| Total Current Liabilities | 134.6 M | |
| Other Operating Expenses | 529.9 M | |
| Non Current Assets Total | 694.9 M | |
| Forward Price Earnings | 29.1545 | |
| Non Currrent Assets Other | 24 M | |
| Stock Based Compensation | 51.9 M |
Additional Tools for Core Stock Analysis
When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.